ASX-Dividend-Report-Banner

Apollo Cancer Centres launches India's 1st AI-Precision Oncology Centre

January 23, 2024 07:27 PM AEDT | By Cision
Follow us on Google News: https://kalkinemedia.com/resources/assets/public/images/google-news.webp
 Apollo Cancer Centres launches India's 1st AI-Precision Oncology Centre
Image source: Kalkine Media

BENGALURU, India, Jan. 23, 2024 /PRNewswire/ -- In a significant move that will substantially enhance the quality of oncology care, Apollo Cancer Centre, Bengaluru, launched India's first AI-Precision Oncology Centre (POC). The Centre will help the oncologists, patients and care givers to arrive at the best possible results in a time bound manner, using the enormous possibilities offered by AI.

From Left to Right: Mr Uday Davada, Unit Head & Vice President, Apollo Hospitals Enterprise Ltd (AHEL), Mr Manish Mattoo, CEO, AHEL, Karnataka Region, Dr Vijay Agarwal, Lead & Senior Consultant - Medical Oncology, Apollo Cancer Centre (ACC), Bengaluru, Dr Vishwanath S, Senior Consultant, Medical Oncology, ACC, Bengaluru, Ms Suneeta Reddy, Managing Director, AHEL, Mr. Dinesh Gundu Rao, State Minister for Health & Family Welfare, Karnataka, Mr. Harshad Reddy, Director- Apollo Oncology & International, AHEL, Mr Dinesh Madhavan, President-Group Oncology & International, AHEL, Dr Govindaiah Yatheesh, Unit Head, Apollo Speciality Hospital, and Mr John Chandy, Chief Business Officer at ACC
From Left to Right: Mr Uday Davada, Unit Head & Vice President, Apollo Hospitals Enterprise Ltd (AHEL), Mr Manish Mattoo, CEO, AHEL, Karnataka Region, Dr Vijay Agarwal, Lead & Senior Consultant - Medical Oncology, Apollo Cancer Centre (ACC), Bengaluru, Dr Vishwanath S, Senior Consultant, Medical Oncology, ACC, Bengaluru, Ms Suneeta Reddy, Managing Director, AHEL, Mr. Dinesh Gundu Rao, State Minister for Health & Family Welfare, Karnataka, Mr. Harshad Reddy, Director- Apollo Oncology & International, AHEL, Mr Dinesh Madhavan, President-Group Oncology & International, AHEL, Dr Govindaiah Yatheesh, Unit Head, Apollo Speciality Hospital, and Mr John Chandy, Chief Business Officer at ACC

The POC with its comprehensive and specialised medical services ensures accurate diagnosis, real-time insights, cancer risk assessment, treatment protocol and continuum of care, thus providing cutting-edge services in oncology care not seen in India earlier. The AI-POC is designed to be patient-centric, in the most personalized manner. It identifies eligible patients for targeted therapy and immunotherapy, as part of the diagnosis and treatment planning. With the help of conversational AI, it educates the patients and family on diagnosis, treatment FAQs and connections to support groups.

Mr Dinesh Gundu Rao, State Minister for Health & Family Welfare, Karnataka, said, "As we inaugurate India's first AI-Precision Oncology Centre at Apollo Cancer Centres, Bengaluru,  This pioneering initiative not only represents a monumental leap in medical technology but it also symbolises hope and progress for patients and caregivers. Apollo Hospitals' commitment to personalised oncology care through AI is a beacon of compassion and advancement, ensuring a brighter future for those battling cancer."

Ms. Suneeta Reddy, Managing Director, Apollo Hospitals Enterprise Ltd, said, "The launch of AI -POC marks a significant stride in redefining cancer care. This transformative initiative is a testament to our unwavering commitment to personalized medicine and technological innovation. The POC reflects our dedication to providing patients with the most advanced, tailored treatments, underscoring Apollo Hospitals' relentless pursuit of excellence in healthcare delivery."

Dr Vijay Agarwal, Lead & Senior Consultant – Medical Oncology, ACC, Bengaluru, said, "The Centre will support new patient identification through auto-alerts to operational teams that identify eligible patients for POCs. Patient SOS auto-alerts to operational teams on deteriorating patient outcomes for intervention and clinical escalation form another key feature."

Dr Vishwanath S, Senior Consultant, Medical Oncology, ACC, Bengaluru, added, "Clinically, it helps in care pathway compliance by monitoring adherence to standard care pathways. Also for patient management based on genomic, clinical, and pathological profiles. Clinical alerts and recommendations for diagnostic tests, enrollment for Value Based Care & other patient benefit programs are some of the uses. "

Website: Apollo Cancer Centres

For enquires contact: 
Email: anjana_p@apollohospitals.com 

 


Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Pty Ltd (“Kalkine Media, we or us”), ACN 629 651 672 and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary.
The content published on Kalkine Media also includes feeds sourced from third-party providers. Kalkine does not assert any ownership rights over the content provided by these third-party sources. The inclusion of such feeds on the Website is for informational purposes only. Kalkine does not guarantee the accuracy, completeness, or reliability of the content obtained from third-party feeds. Furthermore, Kalkine Media shall not be held liable for any errors, omissions, or inaccuracies in the content obtained from third-party feeds, nor for any damages or losses arising from the use of such content.
Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used on this website are copyrighted to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have made reasonable efforts to accredit the source wherever it was indicated as or found to be necessary.

This disclaimer is subject to change without notice. Users are advised to review this disclaimer periodically for any updates or modifications.

AU_advertise

Advertise your brand on Kalkine Media

Recent Articles

Investing Tips

Previous Next
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.